4Ekstedt M, Franzen LE, Mathiesen UL, et al. Statins in non-alcoholic fatty liver disease and chronically elevated liver enzymes : a histopathological follow-up study [ J ]. J Hepatol,2007,47 ( 1 ) : 135-141.
5Lewis JH, Mortensen ME, Zweig S, et al. Efficacy and safety of high-dose pravastatin in hypercholesterolemic patients with well compensated chronic liver disease: results of a prospective, randomized, double-blind, placebo- controlled, multicenter tria [ J ]. Hepatology, 2007,46 (5) :1453-1463.
7Abel T, Feher J, Dinya E, et al. Efficacy and safety of ezetimibe/simvastatin combination therapy in patients with type 2 diabetes and nonalcoholic fatty liver disease [ J]. Orv Hetil,2009 ,150( 21 ) :989-993.
8Park H, Shima T, Yamaguchi K, et al. Efficacy of long- term ezetimibe therapy in patients with nonalcoholic fatty liver disease [ J ]. J Gastroenterol, 2011, 46 ( 1 ) : 101- 107.
9Dima A, Marinescu AG, Dima AC. Non-alcoholic liver disease and the statins treatment[ J]. Rom J Intern Med, 2012,50( 1 ) :19-25.
10Tandra S, Vuppalanchi R. Use of statins in patients with liver disease [ J ]. Curr Treat Options Cardiovasc Med, 2009,11 (4) :272-278.
3Burnett JR,Huff MW.Cholesterol absorption inhibitors as a therapeutic option for hypercholesterolaemia.Expert Opin Investig Drugs,2006,15:1337-1351.
4Grundy SM,Cleeman JI,Merz CN,et al.Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.Circulation,2004,110:227-239.
5Garcia-Calvo M,Lisnock J.The target Bull HG,of ezetimibe is Niemann-Pick Cl-Like 1 (NPC1L1).Proc Natl Acad Sci U S A,2005,102:8132-8137.
6Sudhop T,Lütjohann D,Kodal A,et al.Inhibition of intestinal cholesterol absorption by ezetimibe in humans.Circulation,2002,106:1943-1948.
7Bays HE,Moore PB,Drehobl MA,et al.Effectiveness and tolerability of ezetimibe in patients with primary hypercholesterolemia:pooled analysis of two phase Ⅱ studies.Clin Ther,2001,23:1209-1230.
8Dujovne CA,Ettinger MP,McNeer JF,et al.Efficacy and safetyof a potent new selective cholesterol absorption inhibitor,ezetimibe,in patients with primary hypercholesterolemia.Am J Cardiol,2002,90:1092-1097.
9Wierzbicki AS,Doherty E,Lumb PJ,et al.Efficacy of ezetimibe in patients with statin-resistant and statin-intolerant familial hyperlipidaemias.Curr Med Res Opin,2005,21:333-338.
10Pearson TA,Denke MA,McBride PE,et al.A community-based,randomized trial of ezetimibe added to statin therapy to attain NCEP ATP Ⅲ goals for LDL cholesterol in hypercholesterolemic patients:the ezetimibe add-on to statin for effectiveness (EASE) trial.Mayo Clin Proc,2005,80:587-595.
9Large V,Peroni O ,Letexier D,et al.Metabolism of lipids in hu- man white adipocyte[J].Diabetes Metab, 2004,30 (4) : 299-309.
10Nicholls S J, Ballantyne CM, Barter P J, et al. Effect of two inten- sive statin regimens on progression of coronary disease[J]. N Engl J Med,2011 ,365(22) :2078-2087.
